Idiopathic hypertrophic pachymeningitis

M J Kupersmith1, V Martin, G Heller

  • 1Institute of Neurology and Neurosurgery at Beth Israel Medical Center, New York Eye and Ear Infirmary, New York University School of Medicine, New York, NY, USA. mkuper@bethisraelny.org

Neurology
|March 10, 2004
PubMed
Abstract

Insights

Idiopathic hypertrophic pachymeningitis (IHP) is a rare dural thickening disorder. MRI aids diagnosis, and while steroids offer initial relief for IHP symptoms like headache and vision loss, relapses are common, often necessitating immunosuppressants.

Area of Science:

  • Neurology
  • Radiology
  • Pathology

Background:

  • Hypertrophic pachymeningitis (HP) is a rare condition causing dura mater thickening, linked to autoimmune diseases, infections, and cancer.
  • Idiopathic hypertrophic pachymeningitis (IHP) is less understood, with limited data on MRI findings, clinical outcomes, and treatment responses.

Purpose of the Study:

  • To evaluate the clinical and laboratory features of idiopathic hypertrophic pachymeningitis (IHP).
  • To correlate Magnetic Resonance Imaging (MRI) findings with clinical course and treatment outcomes.
  • To review existing literature on IHP.

Main Methods:

  • A retrospective case series of 12 patients diagnosed with IHP via imaging and/or biopsy.
  • Documentation of clinical presentation, laboratory results, contrast-enhanced MRI findings, treatment strategies, and patient outcomes.
  • Mean follow-up duration of 3.5 years.

Main Results:

  • Common symptoms included headache (11/12) and vision loss (7/12).
  • MRI showed abnormal dural enhancement, particularly in the sphenoid wing area, correlating with clinical symptoms.
  • Corticosteroids improved vision (7/8) and headache (10/11), but recurrences were frequent (6/12) upon steroid tapering, necessitating immunosuppressive agents (methotrexate or azathioprine) in some cases. MRI correlated with clinical status (80% concordance).

Conclusions:

  • IHP can be suspected based on MRI findings and confirmed by pathological biopsy.
  • Untreated IHP typically leads to severe headache, progressive neurological decline, and vision loss.
  • While initial treatment with corticosteroids is effective, long-term management often requires additional immunosuppressive therapy due to frequent relapses.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...